Fifth Third Bancorp Seagen Inc. Transaction History

Fifth Third Bancorp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	SELL	$191.51 - $216.16 $957 - $1,080	-5 Reduced 9.26%	49 $10,000
Q2 2023 Jul 25, 2023	SELL	$187.64 - $206.25 $4,503 - $4,950	-24 Reduced 30.77%	54 $10,000
Q1 2023 Apr 24, 2023	BUY	$127.59 - $203.08 $4,720 - $7,513	37 Added 90.24%	78 $15,000
Q4 2022 Jan 25, 2023	SELL	$117.37 - $139.17 $1,525 - $1,809	-13 Reduced 24.07%	41 $0
Q3 2022 Oct 25, 2022	BUY	$135.27 - $180.11 $1,217 - $1,620	9 Added 20.0%	54 $7,000

Q2 2022 Aug 04, 2022	BUY	$108.81 - $179.33 $435 - $717	4 Added 9.76%	45 $8,000
Q1 2022 Apr 19, 2022	SELL	$119.61 - $157.85 $8,970 - $11,838	-75 Reduced 64.66%	41 $6,000
Q4 2021 Feb 01, 2022	BUY	$142.57 - $190.86 $4,989 - $6,680	35 Added 43.21%	116 $18,000
Q1 2021 May 07, 2021	SELL	$137.51 - $190.8 $22,826 - $31,672	-166 Reduced 67.21%	81 $11,000
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $40,663 - $52,346	247 New	247 $43,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

Stay updated on Fifth Third Bancorp with notifications on news.